Abstract
: Patients who develop local recurrence (LR) after primary treatment for breast cancer have a variable risk of systemic recurrence (SR) and all data regarding the risk factors for SR or utility of systemic therapy are retrospective in nature. The data from the previously published papers have been tabulated on prognosis and systemic therapy after LR both after modified radical mastectomy (MRM), and after lumpectomy and radiotherapy (LRT). From these data, a scoring system has been formulated through which it is believed patients can be assigned to either a “high-” or “low-” risk group with regard to SR. This may be helpful in attempting to make decisions about the need for systemic therapy. Many patients who have a LR are at high risk for systemic recurrence, especially after modified radical mastectomy (MRM). A reliable means of assessing this risk is mandatory.?
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
